In a study analyzing the effect of CuD on the IκB/NF-κB signaling pathway in doxorubicin-resistant breast cancer cells, it was found that CuD decreased p-NF-κB levels, thereby inhibiting NF-κB translocation to the nucleus (Ku et al., 2015). The gene discussed is NFKB1; the disease is breast carcinoma.